Characterization of resistance of human embryonic stem cells and neural precursor cells to mechanisms of activation of programmed cell death induced by death receptors

KŘIVÁNEK, Jan, Vladimír VINARSKÝ, Tomáš BÁRTA, Dáša DOLEŽALOVÁ, Josef JAROŠ, Ladislav ANDĚRA and Aleš HAMPL. Characterization of resistance of human embryonic stem cells and neural precursor cells to mechanisms of activation of programmed cell death induced by death receptors. In 3rd Annual meeting on stem cells, DNA damage and apoptosis, Krkonoše-Richtrovy boudy, 27.-28.5.2011. 2011.

Basic information

• Original name: Characterization of resistance of human embryonic stem cells and neural precursor cells to mechanisms of activation of programmed cell death induced by death receptors
• Authors: KŘIVÁNEK, Jan, Vladimír VINARSKÝ, Tomáš BÁRTA, Dáša DOLEŽALOVÁ, Josef JAROŠ, Ladislav ANDĚRA and Aleš HAMPL.
• Edition: 3rd Annual meeting on stem cells, DNA damage and apoptosis, Krkonoše-Richtrovy boudy, 27.-28.5.2011, 2011.

Other information

• Original language: English
• Type of outcome: Conference abstract
• Field of Study: Genetics and molecular biology
• Country of publisher: Czech Republic
• Confidentiality degree: is not subject to a state or trade secret
• Organization unit: Faculty of Medicine

Links

• AV0Z50390512, plan (intention): Name: Molekulární, buněčné a systémové mechanizmy závažných onemocnění lidského organizmu, jejich diagnostika, terapie a farmakoterapie
• AV0Z50390703, plan (intention): Name: Nové biotechnologie, nanomateriály a kmenové buňky pro užití v regenerativní medicíně
• GAP301/10/1971, research and development project: Name: Exprese, signalizace a funkce receptorů smrti v lidských embryonálních kmenových buňkách.

Investor: Czech Science Foundation

• MSM0021622430, plan (intention): Name: Funkční a molekulární charakteristiky nádorových a normálních kmenových buněk - identifikace cílů pro nová terapeutika a terapeutické strategie

Investor: Ministry of Education, Youth and Sports of the CR, Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies